article thumbnail

Drug Discovery and Medicinal Chemistry in the Era of Automation - Webinar Recap

The Strateos Blog: Drug Discovery

On July 20th, Strateos hosted a webinar entitled Drug Discovery and Medicinal Chemistry in the Era of Automation. The real advantage of machine-executed chemistry is the data moat generated and removal of human biases, which improves data accuracy and interoperability. Daniel Rines, Ph.D.,

article thumbnail

Part 2 Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis - Recap

The Strateos Blog: Drug Discovery

On September 15th, Strateos hosted Part 2 of its Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis. Ben Miles, Ph.D., Head of Product Management at Strateos was joined by Josh Bond, Director of Product Management at PerkinElmer Informatics to discuss this exciting collaboration. Ben Miles, Ph.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Re-Imagining Med Chem Strategies: the Tyranny of the n+1 Compound

DrugBaron

Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. We already talked about choosing carefully a more limited set of compounds to make.

article thumbnail

Women in Stem with Dr Mrunal Jaywant

Drug Target Review

The project has helped the United States Pharmacopeia (USP) deal with the challenges caused by drug product recalls due to unsafe levels of nitrosamine impurities. At USP India, Dr Jaywant oversees the Compendial Development, the Synthetic Chemistry, and the Analytical Research and Development Laboratories.

article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

Kazumi was also a co-founder and CEO of Mitobridge, a start-up company developing mitochondrial drugs for the treatment of muscle and kidney diseases, until its acquisition by Astellas Pharma in 2018. Lisa is a senior pharmaceutical executive with more than 20 years of experience in research and drug discovery.

article thumbnail

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

The Pharma Data

FDA Investigational New Drug (“IND”)-enabling pharmacology studies. About Eurofins Discovery: Eurofins Discovery, a business operating under the Eurofins BioPharma Services division, has supported drug discovery research for over 40 years. About BetterLife Pharma: BetterLife Pharma Inc. For more information, please visit: [link].

FDA 52
article thumbnail

Highlights from SLAS 2022 Conference - Event Recap

The Strateos Blog: Drug Discovery

Strateos’ SVP of Strategy & Operations, Daniel Sipes, echoed this sentiment during his presentation on how automated labs are accelerating medicinal chemistry (MedChem) cycles for drug discovery. The model quality data generated is well-suited to support AI and machine learning tools.”